Taxol precursors produced in engineered E coli
Cost-effective, large-scale production of oncology drug Taxol (paclitaxel) intermediates could eventually be achieved using engineered Escherichia coli.
Archives for October 3, 2010
Sanofi launches hostile Genzyme bid; Pfizer close on Uplyso Brazil deal
French drugmaker Sanofi Aventis has tabled an $18.5m, $69 per share, hostile takeover bid for Genzyme after failing to secure an amicable acquisition.